Q32 Bio Inc.

@Q32Bio

Clinical-stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases.

830 Winter Street, Waltham, MA Joined May 2020

32 Following 256 Followers 193 Posts

Latest posts 5

Q32 Bio Inc. @Q32Bio 2d

We look forward to participating in the 2026 @Jefferies Global Healthcare Conference in London. Join our fireside chat on Wednesday, November 18 at 12 p.m. GMT (7 a.m. ET). Find webcast details here: bit.ly/48f1ijd

#JefferiesHealthcare

Q32 Bio Inc. @Q32Bio Nov 5

We’re looking forward to the 10th #DermatologyDrugDevelopmentSummit this week in Boston. Our CMO, José Trevejo, M.D., Ph.D., will share insights on the importance of standardizing global clinical trial conduct. More details below!

Q32 Bio Inc. @Q32Bio Nov 4

Today we reported third quarter 2026 financial results and provided a corporate update. Learn more: bit.ly/3WmD2ck $QTTB

Q32 Bio Inc. @Q32Bio Sep 30

Today we announced additional 36-week results and initial findings from the 16-week off-drug period from Part B of the SIGNAL-AA trial of bempikibart in #alopeciaareata presented in a late-breaking oral and poster presentation at #EADV2026. Learn more: bit.ly/4xQ0rzJ

Q32 Bio Inc. @Q32Bio Sep 28

We were honored to join the alopecia areata community in Boston at the @NAAF_Org’s Walk for Alopecia Celebration – despite the rain, we were able to convert our walk into an indoor dance party!

Thank you to everyone who came out in support of people living with #alopeciaareata.